S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:ACB

Aurora Cannabis (ACB) Stock Forecast, Price & News

$2.93
-0.11 (-3.62%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.78
$3.10
50-Day Range
$2.29
$4.46
52-Week Range
$2.20
$10.64
Volume
7.03 million shs
Average Volume
6.56 million shs
Market Capitalization
$657.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.86
30 days | 90 days | 365 days | Advanced Chart
Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Aurora Cannabis logo

About Aurora Cannabis

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
1,761
Year Founded
N/A

Sales & Book Value

Annual Sales
$191.43 million
Book Value
$3.84 per share

Profitability

Net Income
$-542.59 million
Net Margins
-542.50%
Pretax Margin
-545.11%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$657.29 million
Optionable
Optionable

Company Calendar

Last Earnings
5/12/2021
Today
5/21/2022
Fiscal Year End
6/30/2022
Next Earnings (Estimated)
9/26/2022

MarketRank

Overall MarketRank

1.62 out of 5 stars

Medical Sector

961st out of 1,416 stocks

Medicinals & Botanicals Industry

10th out of 21 stocks

Analyst Opinion: 2.9Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -













Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

Is Aurora Cannabis a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 2 sell ratings and 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view top-rated stocks.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, September 26th 2022.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) issued its quarterly earnings data on Wednesday, May, 12th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.65. The company earned $43.56 million during the quarter, compared to analysts' expectations of $55.17 million. Aurora Cannabis had a negative net margin of 542.50% and a negative trailing twelve-month return on equity of 25.80%.
View Aurora Cannabis' earnings history
.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Shares of Aurora Cannabis reverse split before market open on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for ACB?

7 brokerages have issued twelve-month target prices for Aurora Cannabis' shares. Their forecasts range from $3.75 to $7.00. On average, they expect Aurora Cannabis' share price to reach $5.69 in the next year. This suggests a possible upside of 94.1% from the stock's current price.
View analysts' price targets for Aurora Cannabis
or view top-rated stocks among Wall Street analysts.

Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the following people:
  • Mr. Miguel Martin, CEO & Director (Age 50, Pay $1.66M)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Carey Squires, Exec. VP of Corp. Devel. & Strategy
  • Mr. Andre Jerome, Exec. VP of Global Bus. Devel.
  • Mr. Alex Miller, Exec. VP of Operations & Supply Chain
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Nathalie Clark, Exec. VP, Gen. Counsel & Corp. Sec.
  • Michelle Lefler, VP of Communications & PR
  • Ms. Lori Schick, Exec. VP of HR
What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.83%), Mirae Asset Global Investments Co. Ltd. (0.72%), Dimensional Fund Advisors LP (0.44%), Renaissance Technologies LLC (0.39%), Bank of Montreal Can (0.35%) and TD Asset Management Inc. (0.25%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Sculptor Capital LP, Sculptor Capital LP, Ausdal Financial Partners Inc., Walleye Trading LLC, Bank of Montreal Can, IMC Chicago LLC, Jane Street Group LLC, and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, JPMorgan Chase & Co., Dimensional Fund Advisors LP, Vanguard Group Inc., Group One Trading L.P., Goldman Sachs Group Inc., Commonwealth Equity Services LLC, and Greenwich Wealth Management LLC.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $2.93.

How much money does Aurora Cannabis make?

Aurora Cannabis has a market capitalization of $657.29 million and generates $191.43 million in revenue each year. The company earns $-542.59 million in net income (profit) each year or ($4.630010) on an earnings per share basis.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 1,761 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at (855) 279-4652 or via email at [email protected].

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.